TearCare MGX™ System With and Without Warming Hold
NCT: NCT07365735 · ACTIVE_NOT_RECRUITING
Brief Summary
TearCare is an office-based thermal therapeutic eyelid technology cleared by the US Food and Drug Administration for the treatment of evaporative dry eye disease due to meibomian gland dysfunction. In this randomized study, TearCare procedures using the TearCare MGX System (study device) with the extended Warming hold feature will be compared with TearCare procedures using the TearCare MGX System without the Warming hold (control group).
Frequently Asked Questions
What is TearCare MGX™ System With and Without Warming Hold?
TearCare MGX™ System With and Without Warming Hold is a clinical trial registered under NCT07365735. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07365735?
The current status of NCT07365735 (TearCare MGX™ System With and Without Warming Hold) is: ACTIVE_NOT_RECRUITING.
When did TearCare MGX™ System With and Without Warming Hold start?
TearCare MGX™ System With and Without Warming Hold started on 2026-03-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.